chr6-3012591-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000904.6(NQO2):c.220G>A(p.Glu74Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000904.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NQO2 | NM_000904.6 | c.220G>A | p.Glu74Lys | missense_variant | 4/7 | ENST00000380455.11 | NP_000895.2 | |
NQO2 | NM_001290221.2 | c.220G>A | p.Glu74Lys | missense_variant | 7/10 | NP_001277150.1 | ||
NQO2 | NM_001318940.2 | c.220G>A | p.Glu74Lys | missense_variant | 4/7 | NP_001305869.1 | ||
NQO2 | NM_001290222.2 | c.220G>A | p.Glu74Lys | missense_variant | 4/6 | NP_001277151.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NQO2 | ENST00000380455.11 | c.220G>A | p.Glu74Lys | missense_variant | 4/7 | 1 | NM_000904.6 | ENSP00000369822 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251456Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135898
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 727242
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.220G>A (p.E74K) alteration is located in exon 4 (coding exon 3) of the NQO2 gene. This alteration results from a G to A substitution at nucleotide position 220, causing the glutamic acid (E) at amino acid position 74 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at